Journal article
Assessing the Value of a New Pharmaceutical
Abstract
OBJECTIVES: The authors assessed the feasibility and construct validity of the contingent valuation method for measuring the monetary value to healthy enrollees in a health maintenance organization of a new drug, filgrastim, as prophylaxis against febrile neutropenia after chemotherapy treatment for cancer.
METHODS: A random sample of 220 enrollees from a closed-panel staff-model health maintenance organization who did not have cancer were …
Authors
O'Brien BJ; Goeree R; Gafni A; Torrance GW; Pauly MV; Erder H; Rusthoven J; Weeks J; Cahill M; LaMont B
Journal
Medical Care, Vol. 36, No. 3, pp. 370–384
Publisher
Wolters Kluwer
Publication Date
3 1998
DOI
10.1097/00005650-199803000-00013
ISSN
0025-7079